Section Arrow
Quote
QNCX.NASDAQ
- Quince Therapeutics Inc.
Quotes are at least 15-min delayed:2026/07/19 08:53 EDT
Regular Hours
Last
 18.88
+0.21 (+1.12%)
Day High 
18.88 
Prev. Close
18.67 
1-M High
20.72 
Volume 
40.31K 
Bid
18.06
Ask
18.95
Day Low
17.9 
Open
18.68 
1-M Low
15.1 
Market Cap 
18.26M 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 17.78 
20-SMA 18.17 
50-SMA 20.45 
52-W High 909.98 
52-W Low 15.1 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-210.00/-0.80
Enterprise Value
18.59M
Balance Sheet
Book Value Per Share
16.03
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
0
Operating Revenue Per Share
--
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
ATAIAtaiBeckley Inc7.22+0.07+0.98%-- 
JSPRJasper Therapeutics0.885+0.111+14.34%-- 
LIMNLiminatus Pharma Inc0.123-0.0247-16.72%-- 
IOVAIovance Biotherapeutics5+0.34+7.30%-- 
RXRXRecursion Pharmaceuticals2.945-0.075-2.48%-- 
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Quince Therapeutics Inc is a late-stage biotechnology company dedicated to unlocking the power of a patient's own biology for the treatment of rare diseases. Its proprietary AIDE technology is an inventive drug/device combination platform that uses an automated process to encapsulate a drug into a patient's own red blood cells. Its Phase 3 asset, eDSP, leverages the AIDE technology to encapsulate DSP into a patient's own red blood cells, and is targeted to treat a rare pediatric neurodegenerative disease, A-T.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.